Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Michael A. Repka , Nigel LangleyPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: 1st ed. 2024 Volume: 44 Weight: 0.617kg ISBN: 9783031460142ISBN 10: 3031460146 Pages: 288 Publication Date: 02 December 2023 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsOverview of Pharmaceutical 3D Printing Technologies.- Clinical Benefit of 3D Printed Products.- Characterization or Quality Control of 3D Printed Products.- Polymers for HME based 3D Printing.- Cellulosic Polymers.- API and Polymer Selection Formulation and Process Variables.- Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D.- Future Trends Including Novel Polymeric Excipients Designed for Purpose Bioprinting.ReviewsAuthor InformationDr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks. Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing. Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas. Tab Content 6Author Website:Countries AvailableAll regions |
||||
